scholarly article | Q13442814 |
P2093 | author name string | Wei Liu | |
Ping He | |||
Bei Cheng | |||
Yan-fu Wang | |||
Chun-li Mei | |||
Jing-jing Wan | |||
P2860 | cites work | Atherosclerosis | Q24644573 |
A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis | Q28199913 | ||
Atherosclerosis. the road ahead | Q29618972 | ||
Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice | Q33295303 | ||
Macrophage scavenger receptors and foam cell formation. | Q33782030 | ||
The role of Chlamydia pneumoniae in atherosclerosis--recent evidence from animal models | Q33934178 | ||
Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation | Q34088380 | ||
Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't | Q34572654 | ||
Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis | Q34634764 | ||
Peroxisome proliferator-activated receptor-gamma in macrophage lipid homeostasis | Q34825735 | ||
Consequences of cellular cholesterol accumulation: basic concepts and physiological implications | Q34949033 | ||
Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors | Q35127251 | ||
Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells | Q35488540 | ||
Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation | Q35912822 | ||
PPARalpha in atherosclerosis and inflammation | Q36154953 | ||
Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials | Q36180789 | ||
Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling | Q36195416 | ||
Modulation of PPAR activity via phosphorylation | Q36846134 | ||
Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice | Q37242527 | ||
The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis | Q37605132 | ||
The effect of Chlamydia pneumoniae on the expression of peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells | Q37857559 | ||
Chlamydophilal antigens induce foam cell formation via c-Jun NH2-terminal kinase | Q37858953 | ||
Effect of Chlamydia pneumoniae infection and hyperlipidaemia on the expression of PPARgamma, P50 and c-Fos in aortic endothelial cells in C57bL/6J mice | Q37865245 | ||
Differences in cell activation by Chlamydophila pneumoniae and Chlamydia trachomatis infection in human endothelial cells | Q37866228 | ||
Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae | Q37878008 | ||
Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice | Q37878302 | ||
Infectious causes of atherosclerosis | Q37879248 | ||
Induction of macrophage foam cell formation by Chlamydia pneumoniae | Q37881436 | ||
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries | Q37891287 | ||
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae | Q37892713 | ||
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis | Q41367560 | ||
The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. | Q42497873 | ||
Chlamydia pneumoniaeand atherosclerosis | Q54063686 | ||
Selective uptake of low-density lipoprotein-associated cholesteryl esters by human fibroblasts, human HepG2 hepatoma cells and J774 macrophages in culture | Q72109672 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | macrophage | Q184204 |
Apolipoprotein B | Q648343 | ||
Peroxisome proliferator activated receptor gamma | Q1084878 | ||
Peroxisome proliferator activated receptor alpha | Q7169506 | ||
negative regulation of cholesterol storage | Q15318049 | ||
Chlamydia pneumoniae | Q62869737 | ||
P304 | page(s) | 301-8 | |
P577 | publication date | 2009-03-01 | |
P1433 | published in | Cell Biology International | Q1254690 |
P1476 | title | Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR alpha and PPAR gamma-dependent pathways | |
P478 | volume | 33 |
Q22241306 | Atherosclerosis and infection: is the jury still not in? |
Q37852303 | Chlamydia pneumoniae disturbs cholesterol homeostasis in human THP-1 macrophages via JNK-PPARγ dependent signal transduction pathways |
Q37846181 | Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview |
Q34089711 | Coactivators in PPAR-Regulated Gene Expression |
Q33916075 | Decreased expression of liver X receptor-α in macrophages infected with Chlamydia pneumoniae in human atherosclerotic arteries in situ. |
Q99237959 | Host-Directed Therapy in Tuberculosis: Targeting Host Metabolism |
Q64895108 | Lipid Droplets: A Significant but Understudied Contributor of Host⁻Bacterial Interactions. |
Q33639053 | Manipulation of Host Cholesterol by Obligate Intracellular Bacteria |
Q34459867 | Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses |
Q21090611 | Nocardia brasiliensis induces formation of foamy macrophages and dendritic cells in vitro and in vivo |
Q33805104 | PPARalpha: energy combustion, hypolipidemia, inflammation and cancer |
Q38208513 | The intriguing ultrastructure of lipid body organelles within activated macrophages |
Search more.